🔰 SEASONAL FLU IS RISING — AN APPLIED UNANI MIZAJ-BASED APPROACH
India is experiencing a seasonal rise in influenza during the monsoon/post-monsoon period. Recent surveillance reports describe Influenza A(H1N1) pdm09 as the predominant detected Influenza A strain. Most cases are mild/self-limiting, but high-risk and complicated cases require modern clinical management.
❗So, how can we apply Unani Medicine intelligently?
I would approach Nazla-e-Waba’i / influenza-like illness through clinical phenotype + Mizaj, rather than giving one “anti-flu” prescription to everybody.
1️⃣ Balghami / Cold-Wet phenotype
Features: nasal congestion, watery discharge, phlegmatic cough, heaviness, chills.
Mufradat:
Unnab + Sapistan + Behidana;
Zufa + Asl-us-soos where appropriate.
Nuskha:
Joshanda: Behidana 3 g + Unnab 5 + Sapistan 7–9 + Zufa 3 g → decoction, warm, divided doses.
2️⃣ Safrawi / Hot-Dry phenotype
Features: high fever, thirst, dry irritating cough, burning throat, scanty sputum.
Mufradat: Behidana, Sapistan, Unnab, Banafsha.
Nuskha:
Behidana 3 g + Sapistan 7 + Unnab 5 + Banafsha 3 g → warm decoction; adjust according to clinical response.
3️⃣ Mixed / Mu‘tabar clinical phenotype
Fever + myalgia + nasal symptoms + cough with variable sputum.
Here the objective is Taskeen + Tarqiq-e-Balgham + Islah-e-Sadr, without unnecessarily increasing “heat”.
❗Where does Tiryaq-e-Waba’i fit?
Classically it contains Sibr : Murr Makki : Za‘fran = 2:1:1 and has a long-standing prophylactic role in epidemic conditions. A small randomized study in elderly immunocompromised subjects demonstrated immunological changes, but this is not evidence that it treats influenza virus itself.
Therefore, I would regard it as a selected adjunct/preventive Unani formulation—not a substitute for antiviral therapy in severe/high-risk influenza.
The Applied Unani Principle
Diagnose → assess severity → identify Mizaj/clinical phenotype → select Mufradat → construct Murakkab → monitor response → escalate when necessary.
WHO clinical guidance supports antiviral treatment according to severity/risk, while current evidence for Unani formulations remains much less definitive.
Unani excellence is not “one prescription for every flu patient.”
It is Mizaj + phenotype + severity + evidence + timely integration with modern care.
Comments
Post a Comment